Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the acute renal failure (arf) market size evolved in recent years?

The market size for acute renal failure (ARF) has experienced robust growth lately. The forecast indicates growth from $6.09 billion in 2024 to $6.62 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.6%. This growth during the historic period can be linked to factors like the increase in the aged population, escalating incidence of sepsis, advanced diagnostic capabilities, governmental health initiatives, and the surge in instances of nephrotoxic medication.

What are the predictions for the acute renal failure (arf) market size in the coming years?

It’s anticipated that the Acute Renal Failure (ARF) market will experience robust growth in the coming years, with projections indicating a jump to $9.09 billion by 2029, reflecting a Compound Annual Growth Rate (CAGR) of 8.3%. Such impressive growth over the forecast period can be credited to elements like the expansion of dialysis solutions that can be administered at home, emerging markets, advancements in renal biomarkers, research and development activities in the field of new therapeutic drugs, and augmented demand for non-invasive diagnostics. Looking ahead, exciting trends to watch for within this period includes innovations in Continuous Renal Replacement Therapy (CRRT), the 3D bioprinting of renal tissue, the rise of wearable biosensors, next-generation dialysis machines, and the application of nanotechnology in drug delivery.

Get your acute renal failure (arf) market report here!

https://www.thebusinessresearchcompany.com/report/acute-renal-failure-arf-global-market-report

What key factors are fueling the growth of the acute renal failure (arf) market?

The anticipated surge in the acute renal failure (ARF) market can largely be attributed to the growing incidence of chronic kidney diseases. Chronic kidney disease (CKD) is a long-term condition where the kidneys fail to effectively filter blood due to damage. This increase is largely associated with the growing rates of health conditions like diabetes, hypertension, obesity, and conditions related to aging and lifestyle globally. Acute renal failure, defined by a sudden loss of kidney functionality, can trigger and exacerbate chronic kidney disease, as it can inflict permanent damage on kidney tissues, disrupting filtration, and enhancing the risk of ongoing kidney dysfunction if not managed appropriately. For instance, Kidney Research UK, a non-profit organization based in the UK, reported in June 2023 that approximately 7.2 million people, or above 10% of the population in the UK currently live with chronic kidney disease. Of this total, 3.25 million are grappling with advanced stages of the disease, while an additional 3.9 million are in the early stages. By the year 2033, the number of individuals affected by chronic kidney disease is predicted to escalate to 7.61 million. Hence, the escalating incidence of chronic kidney diseases is fueling the expansion of the acute renal failure (ARF) market.

How is the global acute renal failure (arf) market divided into key segments?

The acute renal failure (ARF) market covered in this report is segmented –

1) By Disease Type: Prerenal Acute Renal Failure, Renal Acute Renal Failure, Postrenal Acute Renal Failure

2) By Drug Type: Diuretics, Vasopressors, Erythropoiesis-Stimulating Agents (ESAS), Phosphate Binders, Calcium and Vitamin D Supplements, Antibiotics, Others Drugs

3) By Route of Administration: Oral, Intravenous

4) By Diagnosis: Computed Tomography (CT) Scan, Kidney Biopsy, Ultrasound

5) By End-Users: Clinics, Hospitals, Home Healthcare, Others End-Users

Subsegments:

1) By Prerenal Acute Renal Failure: Hypovolemia, Decreased Cardiac Output, Renal Artery Stenosis

2) By Renal Acute Renal Failure: Acute Tubular Necrosis, Glomerulonephritis, Interstitial Nephritis

3) By Postrenal Acute Renal Failure: Obstructive Uropathy, Bladder Outlet Obstruction, Kidney Stones

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21083&type=smp

Who are the key firms paving the way for growth in the acute renal failure (arf) market?

Major companies operating in the acute renal failure (ARF) market are Pfizer Inc., Novartis AG, LG Chem Ltd., Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Baxter International Inc., Astellas Pharma Inc., Syensqo, Dr. Reddy’s Laboratories Limited, Zydus Lifesciences Limited, NIKKISO Co., Ltd., Quark Pharmaceuticals Inc., NIPRO Corporation, Alloksys Life Sciences B.V., AM-Pharma B.V., Sentien Biotechnologies, MediBeacon LLC, Angion Biomedica Corp., Atox Bio Ltd.

Which trends are expected to transform the acute renal failure (arf) market?

Leading firms in the acute renal failure (ARF) market are concentrating their efforts towards securing regulatory approval for new drugs, a move designed to broaden their scope and consolidate their stake in the severe acute kidney injury (AKI) treatment sector. Such approvals necessitate formal consent from government or regulatory agencies, allowing for the public distribution and use of drugs, medical devices, or therapies. As an example, CalciMedica., an American clinical-stage biopharmaceutical corporation, was granted FDA approval in February 2024 for an IND application for the Phase 2 trial of Auxora, aimed at assessing its effectiveness in dealing with severe acute kidney injury (AKI) related to acute hypoxemic respiratory failure (AHRF), a disease known for its high fatality rate. The KOURAGE trial is a randomized, double-blind, placebo-controlled study set to recruit around 150 patients with Stage 2 and 3 acute kidney injury (AKI) and acute hypoxemic respiratory failure (AHRF). The study hopes to determine Auxora’s effectiveness by assessing the duration of survival without the necessity of a ventilator or dialysis within 30 days following treatment.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21083

What regions are contributing significantly to the growth of the acute renal failure (arf) market?

North America was the largest region in the acute renal failure (ARF) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute renal failure (ARF) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Hypolipidemics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hypolipidemics-global-market-report

Hypophosphatasia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hypophosphatasia-treatment-global-market-report

Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market Report 2025

https://thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-epi-therapeutics-and-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: